Cargando…
Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
OBJECTIVE: Four-factor prothrombin complex concentrate (4F-PCC) was approved by the US Food and Drug Administration in 2013 for management of severely bleeding patients on warfarin therapy. We describe use of 4F-PCC at a large, suburban academic center. METHODS: We retrospectively reviewed all patie...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Emergency Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273669/ https://www.ncbi.nlm.nih.gov/pubmed/34237811 http://dx.doi.org/10.15441/ceem.20.017 |